` NUTEX (Nutex Befektetesi Nyrt) vs Budapest SE Comparison - Alpha Spread

N
NUTEX
vs
B
Budapest SE

Over the past 12 months, NUTEX has underperformed Budapest SE, delivering a return of -27% compared to the Budapest SE's +40% growth.

Stocks Performance
NUTEX vs Budapest SE

Loading
NUTEX
Budapest SE
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NUTEX vs Budapest SE

Loading
NUTEX
Budapest SE
Difference
www.alphaspread.com

Performance By Year
NUTEX vs Budapest SE

Loading
NUTEX
Budapest SE
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Nutex Befektetesi Nyrt vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Nutex Befektetesi Nyrt
Glance View

Market Cap
2.5B HUF
Industry
Pharmaceuticals

Nutex Befektetesi Nyrt is a HU-based company operating in Pharmaceuticals industry. The company is headquartered in Budapest, Budapest. NUTEX Befektetesi Nyrt is a Hungary-based company engaged in the research, development, manufacturing and distribution of medicinal products. Together with its daughter companies it forms Nutex Group. The Group also provides to its consumers health conserving, health improving, dietary supplement and cosmetic products. Its brand names include Enerex and Organic Mission. NUTEX Befektetesi Nyrt operates in Hungary, Slovakia and the United Kingdom, as well as in Canada, Taiwan, Iran, the United Arab Emirates, Mexico and Hong Kong.

NUTEX Intrinsic Value
2.18 HUF
Overvaluation 86%
Intrinsic Value
Price
N
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett